Trial NCT02713828

View at ClinicalTrials.gov 
Org. Study IDs: PrE0504
Secondary IDs: CDX011-54

Last trial update was posted on 2019-07-16

MeSH Interventions

Antibodies, Monoclonal Glembatumumab vedotin

MeSH Conditions

Carcinoma Carcinoma, Squamous Cell Lung Neoplasms

Other Conditions

Squamous Cell Carcinoma of the Lung

Stopping Reasons

Company discontinued further development of study drug for this indication

Limitations And Caveats

N/A

Result Publications

N/A

Annotations

Category Annotations
No annotators decided on categories yet

Intervention Annotations
# Outdated Intervention Condition
Name Route DrugBank ID